-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Cultural Comic Books for Educating Asian Americans about Hepatitis B in Work In Progress
- Empathy and Risk Assessment in Work In Progress
- Demonstrating Progress: Building a More Equitable Global R&D System in Work In Progress
- This Week in PLOS NTD and PLOS Pathogens: Plant-Virus Ecology; a Genomic Strategy Against P. falciparum; Protective Sand Fly Saliva Proteins; and More in Work In Progress
- Violence Against Women: Implications for our communities, our world and our future in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
What’s Next for Hepatitis C
By Jessica Wapner
Posted: June 9, 2011
Posted: June 9, 2011
Category: Drug Development, Hepatitis C
|
Tagged boceprevir, Charles Rice, HCV, HCV genotypes, hepatitis C, injection drug use, Merck, protease inhibition, Ralf Bartenschlager, telaprevir, Vertex
|
10 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013. 
jessicawapner:
joeltyner (joeltyner)
OblongBooks (Oblong Books & Music)
redhooklibrary (Red Hook Library)
SantaFeSciwrite (Santa Fe Sciwrite)
djsampson (David Sampson)
aniko99 (Aniko )